This impact study, commissioned by Babraham Research Campus and The UKRI Biotechnology and Biological Sciences Research Council (BBSRC), updates the findings of the 2019 report and evaluates developments during and after the COVID-19 pandemic.
Discover the key findings, download the Executive Summary and explore additional materials created to highlight this major piece of work below.
This Impact Report showcases the transformative work across our Campus. From groundbreaking academic research and thriving start-ups to our community-driven approach, we are cultivating an ecosystem where world-class science and innovation can flourish.
The Campus plays a significant role in boosting the UK economy - through infrastructure development, accelerating scientific discovery, creating jobs, and enhancing the global competitiveness of UK life sciences. Our ability to attract international corporations for R&D collaborations further strengthens our economic contributions. To discover more download the Executive Summary here:
Our solid legacy of success continues to fuel investor confidence. Strong investor confidence in our well-established and highly specialised Campus ecosystem attracts substantial investment – more than £1.6bn over the last 15 years. Investment drives research and ultimately commercial success which positively impacts the Cambridge life science cluster, the wider local community and the broader UK economy.
Image Credit: Dasha Tenditna
When Steve Jackson, founder of Adrestia, now Insmed, reflects on the journey of his companies, one element stands out as pivotal: Babraham Research Campus. For him, it’s more than just a place to set up shop; it’s an ecosystem where science and business intersect, and where innovation thrives in an atmosphere of collaboration and shared growth.
Creasallis, a pioneering antibody solutions company led by Zahra Jawad, is at the forefront of developing novel protein engineering solutions for antibody-based therapeutics.
As a participant in the 2021/22 Accelerate@Babraham bio-incubator cohort, Creasallis found itself in an environment that provided more than just lab space – Babraham Research Campus offered the critical infrastructure, collaborative community, and unparalleled support that a young start-up needs to flourish.
PlaqueTec, a pioneering company dedicated to advancing the understanding of coronary artery disease (CAD), is at the forefront of precision medicine.
A critical aspect of PlaqueTec’s progress lies in the dynamic ecosystem of Babraham Research Campus, where cutting-edge science and innovation meet collaboration. For PlaqueTec, being based on Campus has provided access to a network of worldclass expertise and resources that have accelerated the company’s research.
The full report is available to download below.
For any media enquiries, please contact Limewash:
Tel: 07796 583 223
Email: info@limewash.co.uk
If you wish to refer back to the 2019 Impact Report you can download the Executive Summary here. The 2019 report confirmed that strategic public sector funding for life sciences, such as that received by the Babraham Research Campus, delivers significant impact to the UK economy, healthcare and society. Over three quarters of companies surveyed at this time considered their location on Campus as a very important or critically important factor in helping them to access laboratory and office space.
